JPRN-UMIN000000588尚未招募未知
The prevention effect of ARB(Candesartan) upon chronic heart failure of the newly hemo-dialysis patients - The effect of ARB upon newly HD patients
Osaka University, Graduate School of Medicine, Devision of Nephrology0 个研究点目标入组 50 人开始时间: 2010年3月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with cardiovascular and/or cerebrovascular event Patients with severe liver failure and/or lung dysfunction Patients with malignancy which were diagnosed within 3 years Patients who were not suitable for this trial, judged by the attending doctor
研究者
相似试验
进行中(未招募)
1 期
EFFECTS OF ANGIOTENSIN RECEPTOR ANTAGONIST ON CHRONIC NEPHROPATY IN KIDNEY TRANSPLANTED PATIENTS. A PILOT STUDY.EUCTR2004-001673-25-ITOSPEDALE S. RAFFAELE
已完成
不适用
Candesartan may prevent aneurysmal changes in the residual native aorta after thoracic aortic aneurysm surgeryThoracic aortic aneurysmJPRN-UMIN000000756Graduate School of Medicine, Tohoku University150
进行中(未招募)
不适用
Establishing the benefits of a tablet commonly used to treat raised blood pressure in people with Chronic Kidney Disease stage 3b.We plan a large pragmatic trial to test the potential for spironolactone to to reduce overall cardiovascular events and death, to delay the decline in renal function, and to improve surrogate markers for vascular disease in people with stage 3b (eGFR 30-44 ml/min/1.73m2)Chronic Kidney Disease.MedDRA version: 15.1Level: LLTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 100000004857MedDRA version: 15.1Level: PTClassification code 10018355Term: Glomerular filtration rateSystem Organ Class: 10022891 - InvestigationsMedDRA version: 15.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849EUCTR2012-002672-13-GBniversity of Oxford, Clinical Trials and Research Governance Office2,616
已完成
不适用
Effect of direct renin inhibitor(Aliskiren) in chronic heart failure patient with hypertensiochronic heart failureJPRN-UMIN000005719Anjo Kosei Hospital100
已完成
4 期
Effects of angiotensin receptor blocker, Candesartan on renal function in type 2 diabetes with chronic kidney disease and hypertensiotype 2 diabetes with chronic renal disease and hypertentionJPRN-UMIN000002049Juntendo University School of Medicine100
